A detailed history of Wells Fargo & Company transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Wells Fargo & Company holds 22,025 shares of PROK stock, worth $34,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,025
Previous 15,337 43.61%
Holding current value
$34,138
Previous $25,000 116.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.44 - $4.2 $9,630 - $28,089
6,688 Added 43.61%
22,025 $54,000
Q1 2024

May 10, 2024

BUY
$1.2 - $1.76 $2,587 - $3,794
2,156 Added 16.36%
15,337 $25,000
Q4 2023

Feb 09, 2024

BUY
$1.21 - $4.76 $3,277 - $12,894
2,709 Added 25.87%
13,181 $23,000
Q3 2023

Nov 13, 2023

SELL
$4.32 - $13.08 $57,196 - $173,179
-13,240 Reduced 55.84%
10,472 $47,000
Q2 2023

Aug 15, 2023

BUY
$9.0 - $13.0 $212,760 - $307,320
23,640 Added 32833.33%
23,712 $265,000
Q1 2023

May 12, 2023

SELL
$6.1 - $13.78 $42 - $96
-7 Reduced 8.86%
72 $0
Q4 2022

Feb 13, 2023

BUY
$5.47 - $11.38 $54 - $113
10 Added 14.49%
79 $0
Q3 2022

Nov 14, 2022

BUY
$6.6 - $11.25 $455 - $776
69 New
69 $1,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $95.4M
More about PROK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.